Leap Therapeutics
Signal active
Organization
Contact Information
Overview
Leap Therapeutics is a clinical-stage biopharmaceutical company and specializes in the development of targeted and immuno-oncology therapeutics. Leap Therapeutic focus is to identify translational-stage molecules in the areas of cell signaling and immuno-oncology.
About
Industries
Biotechnology, Life Science, Medical, Oncology
Founded
2011
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Leap Therapeutics headquartered in United States, North America, operates in the Biotechnology, Life Science, Medical, Oncology sector. The company focuses on Biotechnology and has secured $42.6B in funding across 160 round(s). With a team of 11-50 employees, Leap Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Post-IPO Equity - Leap Therapeutics, raised $40.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
10
Investors
5
Lead Investors
0
Total Funding Amount
$266.5M
Details
1
Leap Therapeutics has raised a total of $266.5M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2015 | Seed |
Investors
Leap Therapeutics is funded by 14 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Rock Springs Capital | - | FUNDING ROUND - Rock Springs Capital | 40.0M |
| 683 CAPITAL | - | FUNDING ROUND - 683 CAPITAL | 40.0M |
| Leap Therapeutics | - | FUNDING ROUND - Leap Therapeutics | 40.0M |
| Laurion Capital Management | - | FUNDING ROUND - Laurion Capital Management | 40.0M |
Recent Activity
There is no recent news or activity for this profile.